Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan

博士 === 國立臺灣大學 === 健康政策與管理研究所 === 104 === Background: Invasive pneumococcal disease (IPD) is one of the leading causes for hospitalization and deaths among children and the elderly. Pneumococcal conjugate vaccine (PCV) has been introduced by Taiwan government for different target groups of children u...

Full description

Bibliographic Details
Main Authors: Ding-Ping Liu, 劉定萍
Other Authors: 鄭守夏
Format: Others
Language:zh-TW
Published: 2016
Online Access:http://ndltd.ncl.edu.tw/handle/22007870796701445820
id ndltd-TW-104NTU05743012
record_format oai_dc
spelling ndltd-TW-104NTU057430122017-05-14T04:31:47Z http://ndltd.ncl.edu.tw/handle/22007870796701445820 Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan 我國幼兒肺炎鏈球菌疫苗接種政策效益評估 Ding-Ping Liu 劉定萍 博士 國立臺灣大學 健康政策與管理研究所 104 Background: Invasive pneumococcal disease (IPD) is one of the leading causes for hospitalization and deaths among children and the elderly. Pneumococcal conjugate vaccine (PCV) has been introduced by Taiwan government for different target groups of children under 5 years of age since 2009. The effectiveness of the programs has not yet been evaluated. Objectives: 1. To evaluate the PCV coverage and effectiveness for children under 5 years of age; 2. To assess the effectiveness of one dose regimen of PCV for 2-5 years of age; 3. To evaluate the synergy effects for co-administration of PCV and influenza vaccine. Methods: 1. We analyzed long term trend of PCV coverage, IPD prevalence and medical utilization among children under 5 years of age in Taiwan by using CDC registration data and National Health Insurance claim data. 2. For children aged 2-5 years old in 2011-2012, we evaluated the one-dose regimen by comparing medical utilization between vaccinated and non-vaccinated groups. Propensity score matching (1:2) was used to increase the comparability of the two groups; the statistics methods used were generalized linear model with negative binomial regression and logarithmic link and gamma distribution. 3. For children under 5 years of age during 4 influenza seasons from 2009-2013, we classified the subjects into 4 groups: influenza vaccinated, 4-dose PCV vaccinated, both, or none, and compared the all-cause death and medical utilization. In addition, a cost-effectiveness analysis (CEA) was also conducted in this study. Results: 1. The number of IPD cases among children 2-5 years of age have decreased significantly since 2012 (p<.0001); the number of cases under 2 (p<.01) and 5-64 (p<.05) years old have also decreased since 2013. Compared with previous 8 years, pneumococcal infection related costs claimed for National Health Insurance among children 2-5 years of age in 2012 and 2013 decreased 17.5% and 30.3%, respectively. 2. OPD visits related to IPD in vaccinated group is 33% less than that of unvaccinated group (p<.001). Hospitalization related to IPD and pneumonia in vaccinated group is 70% and 31% less than that of unvaccinated group, respectively (p<.001); the cost related to IPD and pneumonia in vaccinated group is 32% and 17% (p<.001) less than unvaccinated group, respectively. 3. Compared with none-vaccinated groups, the three vaccinated groups were all with lower risks for hospitalization caused by pneumonia & flu, respiratory disease and acute otitis media (AOM). The risks of all-cause death of PCV and PCV+FLU groups during flu season were only 18% and 21% of the none vaccinated group, respectively (p<.0001). Nevertheless, there is no synergy effect for those receiving both PCV and flu vaccines. The three vaccination strategies were considered cost-effective with 1.74-1.91 Gross Domestic Product (GDP) per capita needed per life-year gained. The cost of PCV vaccination strategy was higher than influenza vaccination; yet it was still cost-effective with an incremental cost-effectiveness ratio (ICER) per life-year gained reached the WHO criterion. Conclusion: PCV vaccination programs for children were not only effective but also cost-effective; it’s worthy to be included in the national programs. 鄭守夏 2016 學位論文 ; thesis 116 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 國立臺灣大學 === 健康政策與管理研究所 === 104 === Background: Invasive pneumococcal disease (IPD) is one of the leading causes for hospitalization and deaths among children and the elderly. Pneumococcal conjugate vaccine (PCV) has been introduced by Taiwan government for different target groups of children under 5 years of age since 2009. The effectiveness of the programs has not yet been evaluated. Objectives: 1. To evaluate the PCV coverage and effectiveness for children under 5 years of age; 2. To assess the effectiveness of one dose regimen of PCV for 2-5 years of age; 3. To evaluate the synergy effects for co-administration of PCV and influenza vaccine. Methods: 1. We analyzed long term trend of PCV coverage, IPD prevalence and medical utilization among children under 5 years of age in Taiwan by using CDC registration data and National Health Insurance claim data. 2. For children aged 2-5 years old in 2011-2012, we evaluated the one-dose regimen by comparing medical utilization between vaccinated and non-vaccinated groups. Propensity score matching (1:2) was used to increase the comparability of the two groups; the statistics methods used were generalized linear model with negative binomial regression and logarithmic link and gamma distribution. 3. For children under 5 years of age during 4 influenza seasons from 2009-2013, we classified the subjects into 4 groups: influenza vaccinated, 4-dose PCV vaccinated, both, or none, and compared the all-cause death and medical utilization. In addition, a cost-effectiveness analysis (CEA) was also conducted in this study. Results: 1. The number of IPD cases among children 2-5 years of age have decreased significantly since 2012 (p<.0001); the number of cases under 2 (p<.01) and 5-64 (p<.05) years old have also decreased since 2013. Compared with previous 8 years, pneumococcal infection related costs claimed for National Health Insurance among children 2-5 years of age in 2012 and 2013 decreased 17.5% and 30.3%, respectively. 2. OPD visits related to IPD in vaccinated group is 33% less than that of unvaccinated group (p<.001). Hospitalization related to IPD and pneumonia in vaccinated group is 70% and 31% less than that of unvaccinated group, respectively (p<.001); the cost related to IPD and pneumonia in vaccinated group is 32% and 17% (p<.001) less than unvaccinated group, respectively. 3. Compared with none-vaccinated groups, the three vaccinated groups were all with lower risks for hospitalization caused by pneumonia & flu, respiratory disease and acute otitis media (AOM). The risks of all-cause death of PCV and PCV+FLU groups during flu season were only 18% and 21% of the none vaccinated group, respectively (p<.0001). Nevertheless, there is no synergy effect for those receiving both PCV and flu vaccines. The three vaccination strategies were considered cost-effective with 1.74-1.91 Gross Domestic Product (GDP) per capita needed per life-year gained. The cost of PCV vaccination strategy was higher than influenza vaccination; yet it was still cost-effective with an incremental cost-effectiveness ratio (ICER) per life-year gained reached the WHO criterion. Conclusion: PCV vaccination programs for children were not only effective but also cost-effective; it’s worthy to be included in the national programs.
author2 鄭守夏
author_facet 鄭守夏
Ding-Ping Liu
劉定萍
author Ding-Ping Liu
劉定萍
spellingShingle Ding-Ping Liu
劉定萍
Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
author_sort Ding-Ping Liu
title Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
title_short Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
title_full Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
title_fullStr Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
title_full_unstemmed Benefits and Effectiveness of Pneumococcal Immunization Policies for Young Children in Taiwan
title_sort benefits and effectiveness of pneumococcal immunization policies for young children in taiwan
publishDate 2016
url http://ndltd.ncl.edu.tw/handle/22007870796701445820
work_keys_str_mv AT dingpingliu benefitsandeffectivenessofpneumococcalimmunizationpoliciesforyoungchildrenintaiwan
AT liúdìngpíng benefitsandeffectivenessofpneumococcalimmunizationpoliciesforyoungchildrenintaiwan
AT dingpingliu wǒguóyòuérfèiyánliànqiújūnyìmiáojiēzhǒngzhèngcèxiàoyìpínggū
AT liúdìngpíng wǒguóyòuérfèiyánliànqiújūnyìmiáojiēzhǒngzhèngcèxiàoyìpínggū
_version_ 1718448913973772288